Soleno Therapeutics (SLNO) Trading 9.4% Higher

Soleno Therapeutics Inc (NASDAQ:SLNO)’s share price traded up 9.4% on Thursday . The stock traded as high as $2.26 and last traded at $1.87. 730,000 shares changed hands during mid-day trading, an increase of 1,303% from the average session volume of 52,022 shares. The stock had previously closed at $1.71.

Several equities analysts recently weighed in on the company. Maxim Group restated a “buy” rating and issued a $25.00 price target on shares of Soleno Therapeutics in a research note on Wednesday, September 13th. ValuEngine upgraded Soleno Therapeutics from a “strong sell” rating to a “sell” rating in a research note on Friday, October 6th. Finally, lowered their price objective on Soleno Therapeutics from $25.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday, November 15th.

The firm has a market cap of $16.70, a price-to-earnings ratio of -1.17 and a beta of 5.99.

In other news, Director Edgar Engleman acquired 1,085,480 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were bought at an average cost of $1.84 per share, for a total transaction of $1,997,283.20. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 69.75% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Soleno Therapeutics (SLNO) Trading 9.4% Higher” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at

Soleno Therapeutics Company Profile

Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

Receive News & Ratings for Soleno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soleno Therapeutics and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit